Retinopathy, nephropathy, peripheral neuropathy and geriatric scale scores in elderly people with Type 2 diabetes

Diabetic Medicine

Volumn 31, Issue 1, 2014, Pages 107-111

  Le Floch, J P ^a   Doucet, J ^b   Bauduceau, B ^c   Verny, C ^d  

^a Villecresnes Medical Hospital   (France)

^b ROUEN UNIVERSITY HOSPITAL   (France)

^c SERVICE D ENDOCRINOLOGIE   (France)

^d BICÊTRE HOSPITAL   (France)

Author keywords

[No Author keywords available]

Indexed keywords

HEMOGLOBIN A1C; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; TRIACYLGLYCEROL;

AGED; ARTICLE; BODY MASS; DAILY LIFE ACTIVITY; DIASTOLIC BLOOD PRESSURE; DIET; DISEASE ASSOCIATION; DISEASE DURATION; FEMALE; FOLLOW UP; GERIATRIC DEPRESSION SCALE; GERIATRIC SCALE SCORE; GLYCEMIC CONTROL; HUMAN; HYPERTENSION; HYPOGLYCEMIA; KIDNEY DISEASE; MAJOR CLINICAL STUDY; MALE; MINI MENTAL STATE EXAMINATION; MORBIDITY; MORTALITY; MULTICENTER STUDY; NON INSULIN DEPENDENT DIABETES MELLITUS; NUTRITIONAL ASSESSMENT; OBSERVATIONAL STUDY; PERIPHERAL NEUROPATHY; PROSPECTIVE STUDY; RETINOPATHY; SCORING SYSTEM;

ACTIVITIES OF DAILY LIVING; AGED; AGED, 80 AND OVER; BLOOD PRESSURE; DIABETES MELLITUS, TYPE 2; DIABETIC ANGIOPATHIES; DIABETIC NEPHROPATHIES; DIABETIC NEUROPATHIES; DIABETIC RETINOPATHY; DISEASE PROGRESSION; FEMALE; FOLLOW-UP STUDIES; GERIATRIC ASSESSMENT; HUMANS; MALE; PROSPECTIVE STUDIES; RISK ASSESSMENT;

EID: 84890150005     PISSN: 07423071     EISSN: 14645491     Source Type: Journal    
DOI: 10.1111/dme.12327     Document Type: Article

References (25)

1. Fagot-Campagna A, Bourdel-Marchasson L, Simon D. Burden of diabetes in an aging population: prevalence, incidence, mortality, characteristics and quality of care. Diabetes Metab 2005; 31: S35-52.
2. Shaw JE, Sicree RA, Zimmet PZ. Global estimates of the prevalence of diabetes for 2010 and 2030. Diabetes Res Clin Pract 2010; 87: 4-14.
3. Wild S, Roglic G, Green A, Sicree R, King H. Global prevalence of diabetes: estimates for the year 2000 and projections for 2030. Diabetes Care 2004; 27: 1047-1053.
4. Kirkman MS, Briscoe VJ, Clark N, Florez H, Haas LB, Halter JB et al. Diabetes in older adults. Diabetes Care 2012; 35: 2650-2664.
5. Lee SJ, Boscardin WJ, Cenzer IS, Huang ES, Rice-Trumble K, Eng C. The risks and benefits of implementing glycemic control guidelines in frail older adults with diabetes mellitus. J Am Geriatr Soc 2011; 59: 666-672.
6. Kalyani RR, Saudek CD, Brancati FL, Sevin E. Association of diabetes, comorbidities, and A1c with functional disability in older adults: results from the National Health and Nutrition Examination Survey (NHANES), 1999-2006. Diabetes Care 2010; 33: 1055-1060.
7. Sinclair AJ, Paolisso G, Castro M, Bourdel-Marchiasson I, Gadsby R, Rodriguez Mañas L. European Working Party for Older People. clinical guidelines for type 2 diabetes mellitus. Executive summary. Diabetes Metab 2011; 2011: S27-38.
8. American Diabetes Association. Executive summary: standards of medical care in diabetes-2012. Diabetes Care 2012; 35: S4-S10.
9. Turner RC, Holman RR, Cull CA, Stratton IM, Matthews DR, Frighi V et al. Intensive blood-glucose control with sulfonylureas or insulin compared with conventional treatment and risks of complications in patients with type 2 diabetes (UKPDS 33). Lancet 1998; 352: 837-853.
10. Huang ES, Liu JY, Moffet HH, John PM, Karter AJ. Glycemic control, complications, and death in older diabetic patients. The Diabetes and Aging Study. Diabetes Care 2011; 34: 1329-1336.
11. Zekry D, Frangos E, Graf C, Michel JP, Gold G, Krause KH et al. Diabetes, comorbidites and long-term mortality in older patients admitted for geriatric inpatient care. Diabetes Metab 2012; 38: 149-155.
12. Sinclair AJ, Conroy SP, Bayer AJ. Impact of diabetes on physical function in older people. Diabetes Care 2008; 31: 233-235.
13. Doucet J, Le Floch JP, Bauduceau B, Verny Ch, the SFD/SFGG Intergroup. GERODIAB: Glycaemic control and 5-year morbidity-mortality of type 2 diabetic patients aged 70 years and older: 1. Description of the population at inclusion. Diabetes Metab 2012; 38: 523-530.
14. Doucet J, Druesne L, Capet C, Gréboval E, Landrin I, Moirot P et al. Risks factors and management of diabetes in elderly French patients. Diabetes Metab 2008; 34: 574-580.
15. Hugonot-Diener L, Barbeau E, Michel BF, Thomas-Antétion C, Robert P. Gremoire: tests et échelles de la Maladie d'Alzeimer et des syndromes apparentés. Collection GRECO (Groupe de REflexion sur les Evaluations Cognitives) (Tests and scales for Alzeimer disease and similar syndromes). GRECO collection. Paris: Solal Editions, 2008. Available at www.site-greco.net Last accessed 07 October 2013.
16. American Diabetes Association (ADA) and the European Association for the Study of Diabetes (EASD). Position statement. Management of hyperglycemia in type 2 diabetes: a patient-centered approach. Diabetes Care 2012; 35: 1364-1379.
17. Yau JW, Rogers SL, Kawasaki R, Lamoureux EL, Kowalski JW, Bek T et al. Global prevalence and major risk factors of diabetic retinopathy. Diabetes Care 2012; 35: 556-564.
18. Lin MY, Gutierrez PR, Stone KL, Yaffe K, Ensrud KE, Fink HA et al. Study of Osteoporotic Fractures Research Group: vision impairment and combined vision and hearing impairment predict cognitive and functional decline in older women. J Am Geriatr Soc 2004; 52: 1996-2002.
19. Longstreth WT Jr, Marino Larsen EK, Klein R, Wong TY, Sharrett AR, Lefkowitz D et al. Associations between findings on cranial magnetic resonance imaging and retinal photography in the elderly. The Cardiovascular Health Study. Am J Epidemiol 2006; 165: 78-84.
20. Kilpatrick ES, Rigby AS, Atkin SL, Frier BM. Does severe hypoglycemia influence microvascular complications in type 1 diabetes? An analysis of the Diabetes Control and Complications Trial database. Diabet Med 2012; 29: 1195-1198.
21. Charles M, Ejskjaer N, Witte DR, Borch-Johnsen K, Lauritzen T, Sandbaek A. Prevalence of neuropathy and peripheral arterial disease and the impact of treatment in people with screen-detected type 2 diabetes: the ADDITION-Denmark study. Diabetes Care 2011; 34: 2244-2249.
22. Munsi M, Grande L, Hayes M, Ayres D, Suhl E, Capelson R et al. Cognitive dysfunction is associated with poor diabetes control in older adults. Diabetes Care 2006; 29: 1794-1799.
23. Cukierman-Yaffe T, Gerstein HC, Williamson JD, Lazar RM, Lovato L, Miller ME et al. for the Action to Control Cardiovascular Risk in Diabetes-Memory in Diabetes (ACCORD-MIND) Investigators. Relationship between baseline glycemic control and cognitive function in individuals with type 2 diabetes and other risk factors: the Action to Control Cardiovascular Risk in Diabetes-Memory in Diabetes (ACCORD-MIND) trial. Diabetes Care 2009; 32: 221-226.
24. Spauwen PJJ, Köhler S, Verhey FRJ, Stehouwer CDA, Van Boxtel MPJ. Effects of Type 2 diabetes on 12-year cognitive change. Results from the Maastricht Study. Diabetes Care 2013; 36: 1554-1561.
25. Yaffe K, Falvey CM, Hamilton N, Harris TB, Simonsick EM, Strotmeyer ES et al., for the Heath ABC Study. Association between hypoglycemia and dementia in a biracial cohort of older adults with diabetes mellitus. JAMA Intern Med 2013; 173: 1300-1306.